Furthermore, allele-specific analyses showed that CYP2C9*2 was a poor risk predictor (marginal effects) in contrast to CYP2C9*3 , which clearly showed a highly significant association with increased risk of upper GI adverse events and GI bleeding ( Macías et al., 2020 ).
1
—
—